Literature DB >> 21283148

Patent foramen ovale: anatomy, outcomes, and closure.

Patrick A Calvert1, Bushra S Rana, Anna C Kydd, Leonard M Shapiro.   

Abstract

Patent foramen ovale (PFO) is a normal fetal communication between the right and left atria that persists after birth. PFO is a common finding that occurs in 20-34% of the population, although its prevalence decreases with age. In most cases, a PFO poses no threat to health. However, some PFOs have the ability to open widely under certain hemodynamic conditions, which enables any bloodborne material, such as thrombi, air, or vasoactive substances, to pass from the venous to the arterial circulation, with the potential to cause a cerebrovascular event. PFO has been linked to several conditions, including cryptogenic stroke, migraine with aura, decompression illness, and systemic arterial embolism. However, the data that support PFO closure in these conditions are mostly from nonrandomized cohort series, and are often contradictory. In this Review, we discuss the existing data on PFO closure, including results of the first randomized, controlled trial comparing device closure of PFO with medical therapy for cryptogenic stroke, and we examine controversies in the literature as well as ongoing studies. We also focus on the anatomy of a PFO and how it impacts on the procedure of PFO closure with a percutaneous device.

Entities:  

Mesh:

Year:  2011        PMID: 21283148     DOI: 10.1038/nrcardio.2010.224

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  121 in total

1.  Occlusion of PFO with a dedicated adjustable device: influence on one year outcome.

Authors:  Franz-Xaver Kleber; Anne Winkelmann; Anna Stretz; Steffen-Mark Sonntag; Leonhard Bruch; Grit Rademacher; Paul Sparenberg; Ingo Schmehl
Journal:  EuroIntervention       Date:  2010-08       Impact factor: 6.534

2.  Shunt-associated migraine responds favorably to atrial septal repair: a case-control study.

Authors:  Gian P Anzola; Giovanni B Frisoni; Eva Morandi; Francesco Casilli; Eustaquio Onorato
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

3.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

4.  Lack of association between migraine headache and patent foramen ovale: results of a case-control study.

Authors:  Pallav Garg; Stephen J Servoss; Justina C Wu; Zahid H Bajwa; Magdy H Selim; Alexis Dineen; Richard E Kuntz; E Francis Cook; Laura Mauri
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

5.  Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.

Authors:  Ardan M Saguner; Andreas Wahl; Fabien Praz; Stefano F de Marchi; Heinrich P Mattle; Stéphane Cook; Stephan Windecker; Bernhard Meier
Journal:  Catheter Cardiovasc Interv       Date:  2010-10-07       Impact factor: 2.692

6.  Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.

Authors:  Joaquín Serena; Joan Marti-Fàbregas; Estevo Santamarina; Juan Jesús Rodríguez; María Jesús Perez-Ayuso; Jaime Masjuan; Tomás Segura; Jaime Gállego; Antonio Dávalos
Journal:  Stroke       Date:  2008-09-25       Impact factor: 7.914

7.  Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea.

Authors:  T D Bradley; D Martinez; R Rutherford; F Lue; R F Grossman; H Moldofsky; N Zamel; E A Phillipson
Journal:  J Appl Physiol (1985)       Date:  1985-11

8.  Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).

Authors:  Florian Krizanic; Horst Sievert; Dietrich Pfeiffer; Thomas Konorza; Markus Ferrari; Hans-Reiner Figulla
Journal:  Clin Res Cardiol       Date:  2008-08-11       Impact factor: 5.460

9.  HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicentre experience.

Authors:  Kai Billinger; Stefan H Ostermayer; Mario Carminati; Joseph V Degiovanni; Peter Ewert; John Hess; Fernando A Maymone-Martins; Shakeel A Qureshi; Anthony P Salmon; Martin Schneider; Neil Wilson; Horst Sievert
Journal:  EuroIntervention       Date:  2006-02       Impact factor: 6.534

10.  Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.

Authors:  Andreas Wahl; Tony Tai; Fabien Praz; Markus Schwerzmann; Christian Seiler; Krassen Nedeltchev; Stephan Windecker; Heinrich P Mattle; Bernhard Meier
Journal:  JACC Cardiovasc Interv       Date:  2009-02       Impact factor: 11.195

View more
  36 in total

1.  Significance of Patent Foramen Ovale in Patients with GOLD Stage II Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Dario Martolini; Rebecca Tanner; Claire Davey; Mehul S Patel; Davide Elia; Helen Purcell; Paolo Palange; Nicholas S Hopkinson; Michael I Polkey
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

2.  Echocardiographic Follow-Up of Patent Foramen Ovale and the Factors Affecting Spontaneous Closure.

Authors:  Ali Yildirim; Alperen Aydin; Tevfik Demir; Fatma Aydin; Birsen Ucar; Zubeyir Kilic
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

3.  Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow.

Authors:  Mary F Lopez; David A Sarracino; Maryann Vogelsang; Jennifer N Sutton; Michael Athanas; Bryan Krastins; Alejandra Garces; Amol Prakash; Scott Peterman; Zareh Demirjian; Ignacio Inglessis-Azuaje; Kathleen Feeney; Mikaela Elia; David McMullin; G William Dec; Igor Palacios; Eng H Lo; Ferdinand Buonanno; MingMing Ning
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

Review 4.  Role of PFO Closure in Ischemic Stroke Prevention.

Authors:  Nicholas D Osteraas; Alejandro Vargas; Laurel Cherian; Sarah Song
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

Review 5.  Importance of the Left Atrium: More Than a Bystander?

Authors:  Kalie Y Kebed; Karima Addetia; Roberto M Lang
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

6.  Concentric Tube Robot Design and Optimization Based on Task and Anatomical Constraints.

Authors:  Christos Bergeles; Andrew H Gosline; Nikolay V Vasilyev; Patrick J Codd; Pedro J Del Nido; Pierre E Dupont
Journal:  IEEE Trans Robot       Date:  2015-02-03       Impact factor: 5.567

Review 7.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

8.  Percutaneous steerable robotic tool delivery platform and metal microelectromechanical systems device for tissue manipulation and approximation: closure of patent foramen ovale in an animal model.

Authors:  Nikolay V Vasilyev; Andrew H Gosline; Evan Butler; Nora Lang; Patrick J Codd; Haruo Yamauchi; Eric N Feins; Chris R Folk; Adam L Cohen; Richard Chen; David Zurakowski; Pedro J del Nido; Pierre E Dupont
Journal:  Circ Cardiovasc Interv       Date:  2013-07-30       Impact factor: 6.546

Review 9.  Uteroplacental circulation and fetal vascular function and development.

Authors:  Kent L Thornburg; Samantha Louey
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

10.  Implantable cardiac devices with patent foramen ovale--a risk factor for cardioembolic stroke?

Authors:  Christopher V DeSimone; Daniel C DeSimone; Nikhil A Patel; Paul A Friedman; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2012-08-07       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.